TMates

TMates's all-in monthly figures at the maintenance basis are $297 for tirzepatide and $249 for semaglutide, including every mandatory recurring fee, as captured 2026-07-14.

On the current record, tirzepatide runs $297 a month billed monthly, and $167 a month on a twelve-month plan; semaglutide runs $249 a month billed monthly, and $158 a month on a twelve-month plan. Commitment terms on file: 12-month plan or month-to-month; substantial difference in rates. Longer terms bill as stated at checkout — screenshot the plan page you actually buy from.

Computed from the current record: $2,004 for tirzepatide on the committed twelve-month term and $1,896 for semaglutide on the committed twelve-month term. The full-year framing is the honest one — the twelve-month cost guide shows why.

Structured titration; medication and provider visits included in price Budget from the maintenance dose, not the starter — the teaser-index analysis shows how start-dose pricing distorts annual totals.

Cash pay If you have commercial coverage, Medicare, or Medicaid, run the indication doors before paying cash anywhere — a covered brand pen at a $25–$50 copay beats every cash program on this site.

On record: Partner 503A pharmacy (not publicly named) (503A). Whatever name appears on your own label is the one to check — the license-verification guide is a fifteen-minute workflow, and the label-reading guide covers the rest.

States served on record: Confirm at intake. State availability shifts with pharmacy licensure and telehealth rules, so the intake screen is the final word — our fifty-one state guides in the Journal record which programs served each state at last review.

No — the program price is all-inclusive with no separate membership.

Status printed on the record — tirzepatide: reported, captured 2026-07-14; semaglutide: reported, captured 2026-07-14. The methodology defines each status, the sources page holds the capture ledger, and a dated checkout screenshot from any reader upgrades a status through the corrections desk.

Per provider terms Always screenshot the terms shown at your own checkout; that capture is what governs your plan.

Computed from the plans on record: $2,004 for tirzepatide on its twelve-month plan and $1,896 for semaglutide on its twelve-month plan. Where the figure rides a committed plan, the per-month saving is real and the exit terms matter — read the refund language before prepaying, and note that promotional rates are labeled wherever they apply.

Against the 34 programs with a rankable tirzepatide maintenance price in our database, the median all-in monthly figure is $299; TMates's $297 sits below that median. The full computed ranking, promos labeled, is on the cheapest-provider pages.